A June 10 Medical Devices Dispute Resolution Panel for FzioMed Inc.’s Oxiplex spine surgery gel will be postponed to give FDA’s device center time to consider whether new data from the company can support approval of its so-far spurned device.
FzioMed announced an agreement with CDRH to hold off on the dispute-resolution meeting on May 28, although it noted that...